Minden Collamore

1.5k citations
8 papers · 1.2k · 1 hit paper · h-index 7

Impact in

Papers in

    • Histone Deacetylase Inhibitors Research 2
    • S100 Proteins and Annexins 1
    • Polyomavirus and related diseases 1
    • Cancer Treatment and Pharmacology 1

Minden Collamore

8 papers receiving 1.2k citations

Minden Collamore's Hit Papers

Phase II Trial of Sorafenib in Metastatic Thyroid Cancer 2009 · 430 citations
4300+5+11Years since publication100200300400

Peers

Minden Collamore
Comparison fields: 5 of 73
  • Endocrinology, Diabetes and Metabolism 618
  • Endocrine and Autonomic Systems 122
  • Aging 29
  • Oncology 356
  • Molecular Biology 353
Replace Zoë D. Burke with:
Zoë D. Burke United Kingdom
Sandra Meulemans Belgium
Katja Kiseljak‐Vassiliades United States
Janice D. Rone United States
Stephen Leong United States
J.P. Estève France
Mary B. Breslin United States
Ayse Bilge Ozel United States
Jamila Gupte United States
Sabrina Semprini United Kingdom
Minden Collamore relative to Zoë D. Burke United Kingdom Zoë D. Burke's profile →
Citations per field
00.5×7.5×
Zoë D. Burke · 1×
Citations per year

Countries citing papers authored by Minden Collamore

Since Specialization
Citations

This map shows the geographic impact of Minden Collamore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minden Collamore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minden Collamore more than expected).

Fields of papers citing papers by Minden Collamore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minden Collamore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minden Collamore. The network helps show where Minden Collamore may publish in the future.

Co-authors

The 25 scholars most cited alongside Minden Collamore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Minden Collamore Line = papers co-authored together Minden Collamore links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1
Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
Hit paper breakdown →
2009430
2 2010288
3 2006192
4 2002132
5 2008129
6 200934
7 200626
8 20055

About Minden Collamore

Minden Collamore is a scholar working on Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism, Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems, having authored 8 papers that have together received 1.2k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (3 papers), Histone Deacetylase Inhibitors Research (2 papers), Circadian rhythm and melatonin (1 paper), Light effects on plants (1 paper), S100 Proteins and Annexins (1 paper), Polyomavirus and related diseases (1 paper), Multiple Myeloma Research and Treatments (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (618 citations), Endocrine and Autonomic Systems (122 citations), Aging (29 citations), Oncology (356 citations) and Molecular Biology (353 citations). Minden Collamore has collaborated with scholars based in United States. Frequent co-authors include Manisha H. Shah, Daria Arbogast, Michael R. Grever, Richard T. Kloos, Matthew D. Ringel, Michael V. Knopp, Lai Wei, Jiachao Liang, Nathan C. Hall and Motoyasu Saji. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism and American Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact